Is Mersana Therapeutics, Inc. MRSN stock halal to invest in?

No, as of February 2026, Mersana Therapeutics, Inc. stock (MRSN) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Mersana Therapeutics, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Mersana Therapeutics, Inc. and alternative halal stock options within the Tabadulat app.

How often is Mersana Therapeutics, Inc. MRSN reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Mersana Therapeutics, Inc. MRSN monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Mersana Therapeutics, Inc. MRSN pass the AAOIFI Non Permissible Income criteria?

Yes, as of February 2026, Mersana Therapeutics, Inc. stock (MRSN) passes the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources, such as interest, is below the acceptable threshold set by AAOIFI.

Does Mersana Therapeutics, Inc. MRSN pass the AAOIFI Interest Bearing Investments criteria?

No, as of February 2026, Mersana Therapeutics, Inc. stock (MRSN) does not pass the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments have exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of February 2026, Mersana Therapeutics, Inc. stock (MRSN) passes the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt is below the acceptable threshold set by AAOIFI.

English

العربية

كن أول من يعرف

انضم إلى قائمة الانتظار لدينا للوصول المبكر والحصري إلى منصة تداول تبادلات المتوافقة مع الشريعة الإسلامية. احصل على إشعار عند إطلاق المنصة وابدأ الاستثمار بثقة.

Mersana Therapeutics, Inc.

NASDAQ

متوافق مع الشريعة

ليست الشريعة

MRSN

About

Mersana Therapeutics, Inc.

MRSN

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in the development of novel antibody-drug conjugates (ADCs) aimed at addressing unmet needs in cancer treatment. Its proprietary technology platforms—Dolasynthen and Immunosynthen—enable the creation of ADCs with cytotoxic and immunostimulatory payloads designed to improve efficacy and tolerability over earlier generations. The company’s clinical pipeline features candidates like Emi-Le (XMT-1660), which targets B7-H4, and XMT-2056, focused on a novel epitope of human epidermal growth factor receptor 2 (HER2), both in Phase 1 trials. Collaborations with major biopharmaceutical firms support its research and development efforts. Based in Cambridge, Massachusetts, Mersana contributes to oncology by advancing targeted therapies that combine antibodies with potent drugs to selectively attack cancer cells while minimizing systemic toxicity, thereby playing a significant role in the innovation landscape of cancer therapeutics.

القطاع:

Healthcare

الصناعة:

Biotechnology

الموظفون:

102

الموقع الإلكتروني:

https://www.mersana.com

MRSN

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Mersana Therapeutics, Inc.

About

Mersana Therapeutics, Inc.

MRSN

Frequently asked questions

Is Mersana Therapeutics, Inc. MRSN stock halal to invest in?

How often is Mersana Therapeutics, Inc. MRSN reviewed for Shariah compliance?

Does Mersana Therapeutics, Inc. MRSN pass the AAOIFI Non Permissible Income criteria?

Does Mersana Therapeutics, Inc. MRSN pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Mersana Therapeutics, Inc. MRSN stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.